Serum Institute of India (SII)’s Director, Government and Regulatory Affairs, Prakash Kumar Singh, presented India’s indigenously developed quadrivalent human papillomavirus (qHPV) vaccine ‘CERVAVAC’ before Union Science and Technology Minister Jitendra Singh at his residence on January 26, 2023. CERVAVAC is a vaccine against cervical cancer, and developed by the Department of Biotechnology and SII, a Pune-based pharmaceutical firm. 

Singh said it is “a matter of pride” that the vaccine is “purely indigenous”. He also said that CERVAVAC, if made available, especially for women, the difficulty they go through due to cervical cancer can be done away with. View More